MicroPort Scientific (0853) Price & Analysis

Compare

3 Followers

0853 Stock Chart & Stats

HK$11.42

HK$0.08(1.48%)

At close: Jan 09 4:00 PM EST

HK$11.42

HK$0.08(1.48%)

Day’s Range― - ―

52-Week RangeHK$5.21 - HK$16.28

Previous CloseN/A

Volume6.92M

Average Volume (3M)25.37M

Market Cap

$21.88B

Enterprise ValueHK$26.22B

Total Cash (Recent Filing)$957.62M

Total Debt (Recent Filing)$1.76B

Price to Earnings (P/E)―

Beta1.94

Next Earnings

Mar 26, 2026

EPS EstimateN/A

Last Dividend Ex-Date

Jun 28, 2021

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.22

Shares Outstanding1,912,938,000

10 Day Avg. Volume21,967,342

30 Day Avg. Volume25,373,873

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)2.40

Price to Sales (P/S)1.40

P/FCF Ratio-9.16

Enterprise Value/Market Cap1.20

Enterprise Value/Revenue25.71

Enterprise Value/Gross Profit47.49

Enterprise Value/Ebitda-1.90K

Forecast

1Y Price Target

$15.39

Price Target Upside34.75% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering5

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Cash Flow Management1H recurring NP turned positive at US$1.2mn, and OCF outflow narrowed by 66% due to prudent opex controls and non-core asset disposals.

Export PerformanceStrong export momentum in Medbot, Cardioflow, and vascular segments.

Bears Say

Financial OutlookSales estimates for 2025-27 have been reduced by 2% each due to a more conservative outlook on the TAVI segment.

Sales Performance1H sales fell by 2% YoY with declines in Cardiovascular, Ortho, CRM, Neuro, Endo segments.

MicroPort Scientific News

MicroPort Scientific Reports Mixed Financial Results for Endovastec

The latest update is out from MicroPort Scientific ( ($HK:0853) ). MicroPort Scientific has released the unaudited financial...

10d ago

MicroPort Scientific Adopts New Governance Framework

The latest update is out from MicroPort Scientific ( ($HK:0853) ). MicroPort Scientific Corporation announced that a special...

17d ago

MicroPort Scientific Announces Board Restructuring

The latest announcement is out from MicroPort Scientific ( ($HK:0853) ). MicroPort Scientific Corporation announced changes to its...

1M ago

MicroPort Scientific Announces Board Composition and Committee Roles

MicroPort Scientific ( ($HK:0853) ) has provided an update. MicroPort Scientific Corporation has announced the composition of its...

1M ago

MicroPort Scientific Announces EGM to Revise Governance Documents

MicroPort Scientific ( ($HK:0853) ) has issued an announcement. MicroPort Scientific Corporation has announced an extraordinary general meeting...

1M ago

MicroPort Scientific Announces Strategic Merger to Enhance Cardiac Solutions

MicroPort Scientific ( ($HK:0853) ) has issued an update. MicroPort Scientific has announced a merger agreement involving its...

1M ago

MicroPort Scientific Reports Narrowed Loss Amid Challenges

MicroPort Scientific Corp ( ($MCRPF) ) has released its Q2 earnings. Here is a breakdown of the information...

2M ago

MicroPort’s Firehawk® Stent Gains Global Recognition for Transformative Clinical Impact

An announcement from MicroPort Scientific ( ($HK:0853) ) is now available. MicroPort Scientific Corporation announced that the New...

2M ago

MicroPort Scientific Narrows Losses and Expands Global Reach Amid Market Challenges

MicroPort Scientific ( ($HK:0853) ) has issued an update. MicroPort Scientific Corporation reported a decrease in revenue by...

2M ago

MicroPort’s Endovastec Reports Mixed Financial Results for H1 2025

An announcement from MicroPort Scientific ( ($HK:0853) ) is now available. Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.,...

2M ago

0853 FAQ

What was MicroPort Scientific Corp.’s price range in the past 12 months?

MicroPort Scientific Corp. lowest stock price was HK$5.21 and its highest was HK$16.28 in the past 12 months.

What is MicroPort Scientific Corp.’s market cap?

MicroPort Scientific Corp.’s market cap is $21.88B.

When is MicroPort Scientific Corp.’s upcoming earnings report date?

MicroPort Scientific Corp.’s upcoming earnings report date is Mar 26, 2026 which is in 138 days.

How were MicroPort Scientific Corp.’s earnings last quarter?

MicroPort Scientific Corp. released its earnings results on Aug 29, 2025. The company reported -HK$0.218 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.218.

Is MicroPort Scientific Corp. overvalued?

According to Wall Street analysts MicroPort Scientific Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does MicroPort Scientific Corp. pay dividends?

MicroPort Scientific Corp. pays a Annually dividend of HK$0.043 which represents an annual dividend yield of N/A. See more information on MicroPort Scientific Corp. dividends here

What is MicroPort Scientific Corp.’s EPS estimate?

MicroPort Scientific Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MicroPort Scientific Corp. have?

MicroPort Scientific Corp. has 1,912,938,000 shares outstanding.

What happened to MicroPort Scientific Corp.’s price movement after its last earnings report?

MicroPort Scientific Corp. reported an EPS of -HK$0.218 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.801%.

Which hedge fund is a major shareholder of MicroPort Scientific Corp.?

Currently, no hedge funds are holding shares in HK:0853

MicroPort Scientific Stock Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
$15.39 (34.75% Upside)

Technicals

Fundamentals

Return on Equity

-24.77%

Trailing 12-Months

Asset Growth

-0.59%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MicroPort Scientific Corp.

MicroPort Scientific Corporation (0853) is a global medical device company specializing in the design, manufacturing, and marketing of innovative medical technologies. The company primarily operates in the cardiovascular, orthopedics, and neurosurgery sectors, offering a range of products including stents, heart valves, orthopedic implants, and neurovascular devices. With a strong focus on research and development, MicroPort aims to enhance patient outcomes through advanced medical solutions.

MicroPort Scientific (0853) Earnings & Revenues

Historic Earnings Reports

0853 Stock 12 Month Forecast

Average Price Target

HK$15.39

▲(34.75% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"HK$3","7":"HK$7","11":"HK$11","15":"HK$15","19":"HK$19"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18.192786130501528,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$18.19</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.3883219644,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$15.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.806508011522993,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$8.81</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,7,11,15,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,14.128675856192425,14.46735171238485,14.806027568577274,15.1447034247697,15.483379280962126,15.822055137154551,16.160730993346977,16.4994068495394,16.83808270573183,17.176758561924252,17.515434418116676,17.854110274309104,{"y":18.192786130501528,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,13.912947843415385,14.035895686830768,14.158843530246154,14.281791373661537,14.404739217076923,14.527687060492307,14.650634903907692,14.773582747323076,14.896530590738461,15.019478434153845,15.14242627756923,15.265374120984614,{"y":15.3883219644,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.79,13.406654462424845,13.02330892484969,12.639963387274536,12.256617849699381,11.873272312124227,11.489926774549073,11.10658123697392,10.723235699398764,10.339890161823611,9.956544624248455,9.573199086673302,9.189853549098148,{"y":8.806508011522993,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.86,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.29,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.75,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.88,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.48,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.78,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.76,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.76,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >